Frances Arnold
CIK: 0001665419
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (62 total)
- Oct 29, 2026GOOGL
Alphabet Inc.
Sale(S)Direct82 shares at avg. $284.00$23K - Sep 30, 2026GOOGL
Alphabet Inc.
Sale(S)Direct83 shares at avg. $340.45$28K - Sep 14, 2026GOOGL
Alphabet Inc.
Award(A)Direct1 shares- - Sep 14, 2026GOOGL
Alphabet Inc.
Award(A)Direct1 shares- - Sep 14, 2026GOOGL
Alphabet Inc.
Award(A)Direct11 shares- - Sep 14, 2026GOOGL
Alphabet Inc.
Award(A)Direct0 shares- - Sep 1, 2026GENB
Generate Biomedicines, Inc.
Sale(S)Direct1K shares at avg. $16.00$16K - Jul 30, 2026GOOGL
Alphabet Inc.
Sale(S)Direct82 shares at avg. $333.39$27K - Jul 1, 2026GOOGL
Alphabet Inc.
Award(A)Direct980 shares- - Jun 15, 2026GOOGL
Alphabet Inc.
Award(A)Direct0 shares- - Jun 15, 2026GOOGL
Alphabet Inc.
Award(A)Direct1 shares- - Jun 15, 2026GOOGL
Alphabet Inc.
Award(A)Direct1 shares- - Jun 15, 2026GOOGL
Alphabet Inc.
Award(A)Direct1 shares- - May 29, 2026GOOGL
Alphabet Inc.
Sale(S)Direct102 shares at avg. $381.00$39K - Apr 30, 2026GOOGL
Alphabet Inc.
Sale(S)Direct102 shares at avg. $371.00$38K - Mar 16, 2026GOOGL
Alphabet Inc.
Award(A)Direct0 shares- - Mar 16, 2026GOOGL
Alphabet Inc.
Award(A)Direct1 shares- - Mar 16, 2026GOOGL
Alphabet Inc.
Award(A)Direct1 shares- - Mar 16, 2026GOOGL
Alphabet Inc.
Award(A)Direct1 shares- - Mar 2, 2026GOOGL
Alphabet Inc.
Sale(S)Direct112 shares at avg. $302.99$34K - Feb 26, 2026GENB
Generate Biomedicines, Inc.
Award(A)DirectStock Option (Right to Buy)
29.6K shares- - Jan 29, 2026GOOGL
Alphabet Inc.
Sale(S)Direct102 shares at avg. $340.00$35K - Dec 31, 2025GOOGL
Alphabet Inc.
Sale(S)Direct102 shares at avg. $313.45$32K - Dec 15, 2025GOOGL
Alphabet Inc.
Award(A)Direct1 shares- - Dec 15, 2025GOOGL
Alphabet Inc.
Award(A)Direct1 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 29, 2026 |  GOOGL Alphabet Inc. | Sale(S) | 82 | $284.00 | $23,288 | Direct |
| Sep 30, 2026 | GOOGL Alphabet Inc. | Sale(S) | 83 | $340.45 | $28,257 | Direct |
| Sep 14, 2026 | GOOGL Alphabet Inc. | Award(A) | 1 | - | $0 | Direct |
| Sep 14, 2026 | GOOGL Alphabet Inc. | Award(A) | 1 | - | $0 | Direct |
| Sep 14, 2026 | GOOGL Alphabet Inc. | Award(A) | 11 | - | $0 | Direct |
| Sep 14, 2026 | GOOGL Alphabet Inc. | Award(A) | 0 | - | $0 | Direct |
| Sep 1, 2026 |  GENB Generate Biomedicines, Inc. | Sale(S) | 1,000 | $16.00 | $16,002 | Direct |
| Jul 30, 2026 | GOOGL Alphabet Inc. | Sale(S) | 82 | $333.39 | $27,338 | Direct |
| Jul 1, 2026 | GOOGL Alphabet Inc. | Award(A) | 980 | - | $0 | Direct |
| Jun 15, 2026 | GOOGL Alphabet Inc. | Award(A) | 0 | - | $0 | Direct |
| Jun 15, 2026 | GOOGL Alphabet Inc. | Award(A) | 1 | - | $0 | Direct |
| Jun 15, 2026 | GOOGL Alphabet Inc. | Award(A) | 1 | - | $0 | Direct |
| Jun 15, 2026 | GOOGL Alphabet Inc. | Award(A) | 1 | - | $0 | Direct |
| May 29, 2026 | GOOGL Alphabet Inc. | Sale(S) | 102 | $381.00 | $38,862 | Direct |
| Apr 30, 2026 | GOOGL Alphabet Inc. | Sale(S) | 102 | $371.00 | $37,842 | Direct |
| Mar 16, 2026 | GOOGL Alphabet Inc. | Award(A) | 0 | - | $0 | Direct |
| Mar 16, 2026 | GOOGL Alphabet Inc. | Award(A) | 1 | - | $0 | Direct |
| Mar 16, 2026 | GOOGL Alphabet Inc. | Award(A) | 1 | - | $0 | Direct |
| Mar 16, 2026 | GOOGL Alphabet Inc. | Award(A) | 1 | - | $0 | Direct |
| Mar 2, 2026 | GOOGL Alphabet Inc. | Sale(S) | 112 | $302.99 | $33,935 | Direct |
| Feb 26, 2026 | GENB Generate Biomedicines, Inc. | Award(A) Stock Option (Right to Buy) | 29,561 | - | - | Direct |
| Jan 29, 2026 | GOOGL Alphabet Inc. | Sale(S) | 102 | $340.00 | $34,680 | Direct |
| Dec 31, 2025 | GOOGL Alphabet Inc. | Sale(S) | 102 | $313.45 | $31,972 | Direct |
| Dec 15, 2025 | GOOGL Alphabet Inc. | Award(A) | 1 | - | - | Direct |
| Dec 15, 2025 | GOOGL Alphabet Inc. | Award(A) | 1 | - | - | Direct |
1-25 of 62 transactions
About ARNOLD FRANCES
ARNOLD FRANCES (SEC CIK 0001665419) files insider reports with the SEC as Director of Alphabet Inc. (GOOGL), Director of Generate Biomedicines, Inc. (GENB) and Director of ILLUMINA, INC. (ILMN).
Signal8 holds 41 ownership filings by ARNOLD FRANCES (1 Form 3, 39 Form 4, 1 Form 5), filed between Sep 17, 2024 and Oct 30, 2026. Those filings report 62 transactions, from Sep 16, 2024 to Oct 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on ARNOLD FRANCES's filings is in MOUNTAIN VIEW, CA.
Recent filings by ARNOLD FRANCES
- Oct 29, 2026: Open-market sale of GOOGL shares (Form 4, code S).
- Sep 30, 2026: Open-market sale of GOOGL shares (Form 4, code S).
- Sep 14, 2026: Grants or awards of GOOGL shares (4 lines, Form 4, code A).
- Sep 1, 2026: Open-market sale of GENB shares (Form 4, code S).
- Jul 30, 2026: Open-market sale of GOOGL shares (Form 4, code S).
Other insiders filing for Alphabet Inc. (GOOGL)
- Saraci Marsida, VP, Chief Accounting Officer
- WALKER JOHN KENT, President, Global Affairs, CLO
- Schindler Philipp, SVP, Chief Business Officer
- Porat Ruth, President and CIO
- Ashkenazi Anat, SVP, Chief Financial Officer
- Pichai Sundar, Chief Executive Officer